Clinical trial

A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers

NCT02583542

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-06-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2015-06-01Date precision: month

Registry last updated2020-02-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple-Negative Breast Cancerunresolved

Squamous Cell Lung Cancerunresolved

Non-squamous Cell Lung Cancer With KRAS Mutationsunresolved

Non-squamous Cell Lung Cancer With Wild-type KRASunresolved

Interventions

Sponsors & collaborators

Queen Mary University of Londonlead sponsor

Cancer Research UKcollaborator

AstraZenecacollaborator

Mapped research locations

LondonUnited Kingdom2 ManchesterUnited Kingdom1 BirminghamUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02583542 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.